MedCity News September 16, 2024
This test can be thought of as a crystal ball for cancer survivors and research has found it can predict with near certainty whether a patient’s cancer will recur. So why aren’t more patients getting the test?
There are over 19 million cancer survivors living in the U.S. After enduring the hardships of definitive therapy to cure their cancer (eg, surgery and adjuvant chemotherapy) cancer survivors commonly ask, “Am I cured?” or “How likely is it that my cancer will relapse?” Following the definitive therapy intended to cure the cancer, circulating tumor DNA (ctDNA) shed from microscopic areas of minimal residual disease (MRD) can be detected in the blood. If MRD is detected, patients have a nearly 100% chance of...
Today's Sponsors
Today's Sponsor